Survivin promoter polymorphism and cervical carcinogenesis

A. A. Borbéry, M. Murvai, K. Szarka, J. Kónya, L. Gergely, Z. Hernádi, G. Veress

Research output: Contribution to journalArticle

55 Citations (Scopus)


Background: Survivin, a novel member of the inhibitor of apoptosis family, plays an important role in cell cycle regulation. A common polymorphism at the survivin gene promoter (G/C at position 31) was shown to be correlated with survivin gene expression in cancer cell lines. Aim: To investigate whether this polymorphism could be involved in the development of human papillomavirus (HPV)-associated cervical carcinoma. Methods: Survivin promoter polymorphism was detected in patients with cervical cancer, in patients with equivocal cytological atypia and in a control population using polymerase chain reaction (PCR-restriction fragment length polymorphism (RFLP) and PCR-single strand conformation polymorphism analysis. HPV was typed in patients with cervical cancer and cytological atypia using PCR-RFLP. Results: No statistically significant differences were found in the genotype distributions of the survivin promoter variants among our study groups. Conclusions: The survivin promoter polymorphism at position 31 may not represent an increased risk for the development of cervical cancer, at least in the population studied here.

Original languageEnglish
Pages (from-to)303-306
Number of pages4
JournalJournal of Clinical Pathology
Issue number3
Publication statusPublished - Mar 1 2007

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Survivin promoter polymorphism and cervical carcinogenesis'. Together they form a unique fingerprint.

  • Cite this